In the Clinical Challenge, “Treatment of First-Episode Schizophrenia in a Young Woman,”¹ published online October 30, 2019, there was an error in a quiz answer choice. Answer A was corrected to “Consider the risk of adverse events and which drugs are approved for use” instead of “Commence treatment with oral amisulpride.” In addition, the Discussion and Patient Outcome sections have been corrected to note that the drug amisulpride is not approved for use in the United States but is approved for use in the United Kingdom where the patient was treated. This article has been corrected online.

中文翻译：

---

测验答案中的错误。

在2019年10月30日在线发布的《临床挑战》中，``年轻女性的精神分裂症的治疗'' ^1中，测验答案选择存在错误。答案A已更正为“考虑不良事件的风险以及批准使用哪些药物”，而不是“开始使用口服氨磺必利治疗”。此外，“讨论”和“患者结果”部分已更正，以指出氨磺必利药物未获准在美国使用，但已获批准在接受患者治疗的英国使用。本文已在线更正。